Not Signed In - Perrigo Company Announces FDA Approval For Simvastatin Tablets
Sat, 23 Dec 2006 08:00 AM EST
... The Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market Simvastatin Tablets, USP, 5 mg, 10 mg, 20 mg, 40 mg and 80 mg. Perrigo's partner, Bentley Pharmaceuticals, Inc. is manufacturing the product at their Belmac Laboratories facility located in Zaragoza, Spain. Shipments will begin immediately. [click link for full article] ...
Related Topics
- Simvastatin
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Tacrolimus ointment
- Guaifenesin and Dextromethorphan
- Haloperidol Tablets
- Neostigmine Tablets
- Thiabendazole Tablets
- Working Mothers
- Levonorgestrel Emergency Contraception
- Carbetapentane, Phenylephrine, and Pyrilamine
- Mammography
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets
- Desmopressin Tablets
- Carcinogens
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
email this page
print this page
bookmark this page
feedback on this page
